The structure of neuromelanin as studied by chemical degradative methods

Journal of Neurochemistry

Volumn 86, Issue 4, 2003, Pages 1015-1023

  Wakamatsu, Kazumasa ^a   Fujikawa, Kenichi ^a   Zucca, Fabio A ^b   Zecca, Luigi ^b   Ito, Shosuke ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b CNR   (Italy)

Author keywords

4 amino 3 hydroxyphenylethylamine; Neuromelanin; Pyrrole 2,3,5 tricarboxylic acid; Pyrrole 2,3 dicarboxylic acid; Thiazole 2,3,5 tricarboxylic acid; Thiazole 4,5 dicarboxylic acid

Indexed keywords

4 AMINO 3 HYDROXYPHENYLETHYLAMINE; BENZOTHIAZINE DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; CYSTEINE; CYSTEINYLDOPA; DOPAMINE; HYDRIODIC ACID; HYDROGEN PEROXIDE; NEUROMELANIN; PHENETHYLAMINE DERIVATIVE; PYRROLE 2,3 DICARBOXYLIC ACID; PYRROLE 2,3,5 TRICARBOXYLIC ACID; THIAZOLE 2,3,5 TRICARBOXYLIC ACID; THIAZOLE 4,5 DICARBOXYLIC ACID; UNCLASSIFIED DRUG;

AGED; ANALYTIC METHOD; ARTICLE; BRAIN; CELL PROTECTION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DETOXIFICATION; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYDROLYSIS; OXIDATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN ISOLATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; DICARBOXYLIC ACIDS; FEMALE; HUMANS; HYDROGEN PEROXIDE; HYDROLYSIS; MELANINS; MOLECULAR STRUCTURE; OXIDANTS; OXIDATION-REDUCTION; PYRROLES; SUBSTANTIA NIGRA; THIAZOLES; TYRAMINE;

PARKINSONIA;

EID: 0042731682     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01917.x     Document Type: Article

References (41)

1. Aime S., Fasano M., Bergamasco B., Lopiano L. and Valente G. (1994) Evidence for a glicidic-lipidic matrix in human neuromelanin, potentially responsible for the enhanced iron sequestering ability of substantia nigra. J. Neurochem. 62, 369-371.
2. Barden H. (1975) Histochemical relationship and nature of neuromelanin. Aging 1, 79-117.
3. Ben-Shachar D., Riederer P. and Youdim M. B. (1991) Iron-melanin interaction and lipid peroxidation: implications for Parkinson's disease. J. Neurochem. 57, 1609-1614.
4. Carstam R., Brinck C., Hindemith-Augustsson A., Rorsman H. and Rosengren E. (1991) The neuromelanin of the human substantia nigra. Biochim. Biophys. Acta 1097, 152-160.
5. Cowen D. J. (1986) The melanoneurons of the human cerebellum (nucleus pigmentosus cerebellaris) and homologues in the monkey Neuropathol. Exp. Neurol. 45, 205-221.
6. + binds to neuromelanin. Science 231, 987-989.
7. D'Ischia M. and Prota G. (1997) Biosynthesis, structure and function of neuromelanin and its relation to Parkinson's disease: a critical update. Pigment Cell Res. 10, 370-376.
8. Double K., Zecca L., Costi P., Mauer M., Griesinger C., Ito S., Ben-Shachar D., Bringmann G., Fariello R. G., Riederer P. et al. (2000) Structural characteristics of human substantia nigra neuromelanin and synthetic dopamine melanins. J. Neurochem. 75, 2583-2589.
9. Fornstedt B., Brun A., Rosengren E. and Carlsson A. (1989) The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra. J. Neural. Transm. 1, 279-295.
10. Graham D. G. (1979) On the origin and significance of neuromelanin. Arch. Pathol. Lab. Med. 103, 359-362.
11. Ito S. (1989) Optimization of conditions for preparing synthetic pheomelanin. Pigment Cell Res. 2, 53-56.
12. Ito S. and Fujita K. (1985) Microanalysis of eumelanin and pheomelanin in hair and melanomas by chemical degradation and liquid chromatography. Anal. Biochem. 144, 527-536.
13. Ito S. and Wakamatsu K. (1998) Chemical degradation of melanins: application to dopamine-melanin. Pigment Cell Res. 11, 120-126.
14. Ito S., Fujita K., Yoshioka M., Sienko D. and Nagatsu T. (1986) Identification of 5-S- and 2-S-cysteinyldopamine and 5-S-glutathionyl-dopamine formed from dopamine by high-performance liquid chromatography with electrochemical detection. J. Chromatogr. 375, 134-140.
15. Ito S., Imai Y., Jimbow K. and Fujita K. (1988) Incorporation of sulf-hydryl compounds into melanins in vitro. Biochim. Biophys. Acta 964, 1-7.
16. Jellinger K., Kienzl E., Rumpelmaier G., Riederer P., Stachelberger H., Ben-Shachar D. and Youdim M. B. H. (1992) Iron-melanin complex in substantia nigra of parkinson brains: x-ray microanalysis. J. Neurochem. 59, 1168-1171.
17. 14C] diquat in frogs and mice: accumulation in neuromelanin. Neurosci. Lett. 93, 1-6.
18. Lopiano L., Chiesa M., Digilio G., Giraudo Bergamasco B., Torre E. and Fasano M. (2000) Q-band EPR investigations of neuromelanin in control and Parkinson's disease patients. Biochim. Biophys. Acta 17,306-312.
19. Mann D. M. A. and Yates P. O. (1974) Lipoprotein pigments - their relationship to ageing in the human nervous system. II. The melanin content of pigmented nerve cells. Brain 97, 481-488.
20. Mann D. M. A. and Yates P. O. (1979) The effects of aging on the pigmented nerve cells of the human locus coeruleus and substantia nigra. Acta Neuropathol. 47, 93-97.
21. Napolitano A., Perzzella A., Vincensi M. R. and Prota G. (1995) Oxidative degradation of eumelanins to pyrrole acids: a model study. Tetrahedron 51, 5913-5920.
22. Napolitano A., Vincensi M. R., Di Donato P., Monfrecola G. and Prota G. (2000) Microanalysis of melanins in mammalian hair by alkaline hydrogen peroxide degradation: identification of a new structural marker of pheomelanins. J. Invest. Dermatol. 114, 1141-1147.
23. Odh G., Carstam R., Paulson J., Wittbjer A., Rosengren E. and Rorsman H. (1994) Neuromelanin of the human substantia nigra: a mixed type melanin. J. Neurochem. 62, 2030-2036.
24. Offen D., Ziv I., Gorodin S., Glater E., Hochman A. and Melamed E. (1997) Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson disease. Neurochem. Int. 141, 32-39.
25. Ozeki H., Ito S., Wakamatsu K. and Hirobe T. (1995) Chemical characterization of hair melanins in various coat-color mutants of mice. J. Invest. Dermatol. 105, 361-366.
26. Rosengren E., Linder-Eliasson E. and Carlsson A. (1985) Detection of 5-S-cysteinyldopamine in human brain. J. Neural. Transm. 63 247-253.
27. Smythies J. (1996) On the function of neuromelanin. Proc. R. Soc. Lond. B. Biol. Sci. 263, 487-489.
28. Sulzer D., Bogulavsky J., Larsen K. E., Behr G., Karalekin E., Kleinman M. H., Turro N., Krantz D., Edwards R. H., Greene L. A. et al. (2000) Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc. Natl. Acad. Sci. USA 97, 11869-11874.
29. Van Woert M. H. and Ambani L. M. (1974) Biochemistry of neuromelanin. Adv. Neurol. 5, 215-223.
30. Wakamatsu K. and Ito S. (2002) Advanced chemical methods in melanin determination. Pigment Cell Res. 15, 174-183.
31. Wakamatsu K., Ito S. and Nagatsu T. (1991) Cysteinyldopamine is not incorporated into neuromelanin. Neurosci. Lett. 131, 57-60.
32. Wakamatsu K., Ito S. and Rees J. L. (2002) The usefulness of 4-amino-3-hydroxyphenylalanine as a specific marker of pheomelanin. Pigment Cell Res. 15, 225-232.
33. Wilms H., Rosenstiel P., Sievers J., Deuschl G., Zecca L. and Lucius R. (2003) Activation of microglia by human neuromelanin is NF-kB-dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J. 17, 500-502.
34. Zareba M., Bober A., Korytowski W., Zecca L. and Sarna T. (1995) The effect of synthetic neuromelanin on yield of free hydroxyl radicals generated in model system. Biochim. Biophys. Acta 1271, 343-348.
35. Zecca L., Mecacci C., Seraglia R. and Parati E. (1992) The chemical characterization of melanin contained in substantia nigra of human brain. Biochim. Biophys. Acta 1138, 6-10.
36. Zecca L., Pietra R., Goj C., Mecacci C., Radice D. and Sabbioni E. (1994) Iron and other metals in neuromelanin, substantia nigra and putamen of human brain. J. Neurochem. 62, 1097-1101.
37. Zecca L., Shima T., Stroppolo A., Goj C., Battistron G. A., Gerbasi R., Sarna T. and Swartz H. M. (1996) Interaction of neuromelanin and iron in substantia nigra and other areas of human brain. Neuroscience 73, 407-415.
38. Zecca L., Costi P., Mecacci C., Ito S., Terreni M. and Sonnino S. (2000) Interaction of human substantia nigra neuromelanin with lipids and peptides. J. Neurochem. 74, 1758-1765.
39. Zecca L., Tampellini D., Gerlach M., Riederer P., Fariello R. G. and Sulzer D. (2001) Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. J. Clin. Pathol. Mol. Pathol. 54, 414-418.
40. Zecca L., Fariello R., Riederer P., Sulzer D., Gatti A. and Tampellini D. (2002) The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease. FEBS Lett. 510, 216-220.
41. Zhang F. and Dryhurst G. (1995) Reactions of cysteine and cysteinyl derivatives with dopamine-o-quinone and further insights into the oxidation chemistry of 5-S-cysteinyldopamine: possible relevance to idiopathic Parkinson's disease. Bioorg. Chem. 23, 193-216.